Kidney diseases
Conditions
Interventions
Alleviation of the post-renal biopsy rest requirements compared to the methods previously practiced at our institution
Sponsors
Iwakura Takamasa
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who meet all of the following criteria 1. Patients who are 18 years of age or older and are independent in activities of daily living, and undergo percutaneous renal biopsy in the Department of Nephrology of our hospital. 2. Patients with preserved renal function (eGFR > 30 mL/min/1.73m2). 3. Patients whose blood pressure on the day of renal biopsy is managed to be less than 160/100 mmHg. 4. Patients for whom multiple nephrologists, including the principal investigator (Takamasa Iwakura), a specialist in nephrology, have determined a low risk of complications based on renal morphology depicted by ultrasound. 5. Patients for whom consent has been obtained by signing the informed consent form for participation in this study.
Exclusion criteria
Exclusion criteria: Patients who meet any of the following criteria will not be included in this study: 1. Patients who show coagulation abnormalities (prothrombin time, activated partial thromboplastin time prolongation) or thrombocytopenia (platelet count < 100,000/uL) on admission tests. 2. Patients who show anemia (hemoglobin < 10 g/dL) on admission tests. 3. Patients suspected of renal amyloidosis based on clinical course and blood/urine tests. 4. Patients with difficult blood pressure control in the post-renal biopsy course. 5. Patients who show a hematoma of 40 mL or more on ultrasound examination at the end of renal biopsy. 6. Patients who show a significant increase in hematoma size on ultrasound examination 1 hour after renal biopsy. 7. Patients who show bleeding symptoms (intractable back or abdominal pain, unstable vital signs) within 4 hours after renal biopsy. 8. Patients with gross hematuria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of patients who underwent transfusion or endovascular treatment due to bleeding complications after relaxation of post-renal biopsy rest within 4 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.The proportion of patients who exhibited bleeding symptoms (intractable back or abdominal pain, unstable vital signs) after relaxation of post-renal biopsy rest. 2. The proportion of patients who developed gross hematuria after relaxation of post-renal biopsy rest. 3. The proportion of patients who required extended hospitalization due to complications. | — |
Contacts
Public ContactTakamasa Iwakura
Hamamatsu University school of Medicine
Outcome results
None listed